HTG MOLECULAR DIAGNOSTICS IN's ticker is HTGM and the CUSIP is 40434H203. A total of 23 filers reported holding HTG MOLECULAR DIAGNOSTICS IN in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $45,000 | -42.3% | 74,192 | -2.3% | 0.00% | – |
| Q2 2022 | $78,000 | +254.5% | 75,914 | +380.1% | 0.00% | – |
| Q1 2022 | $22,000 | -74.1% | 15,811 | 0.0% | 0.00% | – |
| Q4 2021 | $85,000 | -4.5% | 15,811 | +1.8% | 0.00% | – |
| Q3 2021 | $89,000 | -2.2% | 15,529 | 0.0% | 0.00% | – |
| Q2 2021 | $91,000 | -13.3% | 15,529 | -19.4% | 0.00% | – |
| Q1 2021 | $105,000 | +14.1% | 19,260 | -0.0% | 0.00% | – |
| Q4 2020 | $92,000 | – | 19,261 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|